Loading...

Health Management International

SGX:588
Snowflake Description

Moderate growth potential with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
588
SGX
SGD452M
Market Cap
  1. Home
  2. SG
  3. Healthcare
Company description

Health Management International Ltd, an investment holding company, provides private healthcare services in Singapore, Malaysia, and Indonesia. The last earnings update was 9 days ago. More info.


Add to Portfolio Compare Print
588 Share Price and Events
7 Day Returns
0%
SGX:588
-3.8%
SG Healthcare
-1.1%
SG Market
1 Year Returns
-14.2%
SGX:588
-21.9%
SG Healthcare
-9.4%
SG Market
588 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Health Management International (588) 0% 0% -0.9% -14.2% 62.7% 201.1%
SG Healthcare -3.8% -9.8% -13% -21.9% -23% -9.9%
SG Market -1.1% -4.5% -3% -9.4% 9.7% -8%
1 Year Return vs Industry and Market
  • 588 outperformed the Healthcare industry which returned -21.9% over the past year.
  • 588 underperformed the Market in Singapore which returned -9.4% over the past year.
Price Volatility
588
Industry
5yr Volatility vs Market

Value

 Is Health Management International undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Health Management International to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Health Management International.

SGX:588 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 5 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.5%
Perpetual Growth Rate 10-Year SG Government Bond Rate 2.3%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for SGX:588
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year SG Govt Bond Rate 2.3%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.68
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.684 (1 + (1- 17%) (23.79%))
0.879
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.88
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.3% + (0.879 * 5.96%)
7.54%

Discounted Cash Flow Calculation for SGX:588 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Health Management International is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

SGX:588 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (MYR, Millions) Source Present Value
Discounted (@ 7.54%)
2019 -108.94 Analyst x3 -101.30
2020 27.71 Analyst x2 23.96
2021 48.02 Analyst x2 38.61
2022 66.40 Est @ 38.26% 49.64
2023 84.64 Est @ 27.48% 58.84
2024 101.50 Est @ 19.92% 65.61
2025 116.36 Est @ 14.64% 69.94
2026 129.08 Est @ 10.94% 72.15
2027 139.86 Est @ 8.35% 72.69
2028 148.99 Est @ 6.53% 72.01
Present value of next 10 years cash flows MYR422.16
SGX:588 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= MYR148.99 × (1 + 2.3%) ÷ (7.54% – 2.3%)
MYR2,909.48
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= MYR2,909.48 ÷ (1 + 7.54%)10
MYR1,406.17
SGX:588 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= MYR422.16 + MYR1,406.17
MYR1,828.33
Equity Value per Share
(MYR)
= Total value / Shares Outstanding
= MYR1,828.33 / 837.34
MYR2.18
SGX:588 Discount to Share Price
Calculation Result
Exchange Rate MYR/SGD
(Reporting currency to currency of SGX:588)
0.329
Value per Share
(SGD)
= Value per Share in MYR x Exchange Rate (MYR/SGD)
= MYR2.18 x 0.329
SGD0.72
Value per share (SGD) From above. SGD0.72
Current discount Discount to share price of SGD0.55
= -1 x (SGD0.55 - SGD0.72) / SGD0.72
24.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Health Management International is available for.
Intrinsic value
24%
Share price is SGD0.545 vs Future cash flow value of SGD0.71861
Current Discount Checks
For Health Management International to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Health Management International's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Health Management International's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Health Management International's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Health Management International's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SGX:588 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in MYR MYR0.06
SGX:588 Share Price ** SGX (2019-05-22) in SGD SGD0.55
SGX:588 Share Price converted to MYR reporting currency Exchange rate (SGD/ MYR) 3.039 MYR1.66
Singapore Healthcare Industry PE Ratio Median Figure of 5 Publicly-Listed Healthcare Companies 27.64x
Singapore Market PE Ratio Median Figure of 322 Publicly-Listed Companies 12.49x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Health Management International.

SGX:588 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SGX:588 Share Price ÷ EPS (both in MYR)

= 1.66 ÷ 0.06

26.18x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Health Management International is good value based on earnings compared to the SG Healthcare industry average.
  • Health Management International is overvalued based on earnings compared to the Singapore market.
Price based on expected Growth
Does Health Management International's expected growth come at a high price?
Raw Data
SGX:588 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 26.18x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts
10.6%per year
Asia Healthcare Industry PEG Ratio Median Figure of 15 Publicly-Listed Healthcare Companies 1.78x
Singapore Market PEG Ratio Median Figure of 120 Publicly-Listed Companies 1.55x

*Line of best fit is calculated by linear regression .

SGX:588 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 26.18x ÷ 10.6%

2.46x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Health Management International is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Health Management International's assets?
Raw Data
SGX:588 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in MYR MYR0.32
SGX:588 Share Price * SGX (2019-05-22) in SGD SGD0.55
SGX:588 Share Price converted to MYR reporting currency Exchange rate (SGD/ MYR) 3.039 MYR1.66
Singapore Healthcare Industry PB Ratio Median Figure of 6 Publicly-Listed Healthcare Companies 2.52x
Singapore Market PB Ratio Median Figure of 432 Publicly-Listed Companies 0.71x
SGX:588 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SGX:588 Share Price ÷ Book Value per Share (both in MYR)

= 1.66 ÷ 0.32

5.18x

* Primary Listing of Health Management International.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Health Management International is overvalued based on assets compared to the SG Healthcare industry average.
X
Value checks
We assess Health Management International's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Health Management International has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Health Management International expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
10.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Health Management International expected to grow at an attractive rate?
  • Health Management International's earnings growth is expected to exceed the low risk savings rate of 2.3%.
Growth vs Market Checks
  • Health Management International's earnings growth is expected to exceed the Singapore market average.
  • Health Management International's revenue growth is expected to exceed the Singapore market average.
Annual Growth Rates Comparison
Raw Data
SGX:588 Future Growth Rates Data Sources
Data Point Source Value (per year)
SGX:588 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts 10.6%
SGX:588 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts 7.6%
Singapore Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 16.8%
Asia Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 12.1%
Singapore Market Earnings Growth Rate Market Cap Weighted Average 5.7%
Singapore Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SGX:588 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in MYR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SGX:588 Future Estimates Data
Date (Data in MYR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-06-30 694 1
2022-06-30 643 1
2021-06-30 597 106 69 4
2020-06-30 553 95 65 5
2019-06-30 513 74 58 5
SGX:588 Past Financials Data
Date (Data in MYR Millions) Revenue Cash Flow Net Income *
2019-03-31 498 79 51
2018-12-31 488 68 53
2018-09-30 475 69 57
2018-06-30 468 77 61
2018-03-31 460 69 56
2017-12-31 452 73 39
2017-09-30 443 83 28
2017-06-30 436 75 21
2017-03-31 430 98 14
2016-12-31 423 93 25
2016-09-30 413 90 25
2016-06-30 398 82 20

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Health Management International's earnings are expected to grow by 10.6% yearly, however this is not considered high growth (20% yearly).
  • Health Management International's revenue is expected to grow by 7.6% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SGX:588 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from Health Management International Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SGX:588 Future Estimates Data
Date (Data in MYR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-06-30
2022-06-30
2021-06-30 0.08 0.09 0.06 4.00
2020-06-30 0.08 0.08 0.07 5.00
2019-06-30 0.07 0.08 0.07 4.00
SGX:588 Past Financials Data
Date (Data in MYR Millions) EPS *
2019-03-31
2018-12-31 0.06
2018-09-30 0.07
2018-06-30 0.07
2018-03-31 0.07
2017-12-31 0.05
2017-09-30 0.04
2017-06-30 0.03
2017-03-31 0.02
2016-12-31 0.04
2016-09-30 0.04
2016-06-30 0.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Health Management International is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Health Management International's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Singapore market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Asia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Health Management International has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Health Management International performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Health Management International's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Health Management International has delivered over 20% year on year earnings growth in the past 5 years.
  • Health Management International's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Health Management International's 1-year earnings growth is negative, it can't be compared to the SG Healthcare industry average.
Earnings and Revenue History
Health Management International's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Health Management International Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SGX:588 Past Revenue, Cash Flow and Net Income Data
Date (Data in MYR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 497.50 50.54 90.73
2018-12-31 488.10 52.99 86.82
2018-09-30 475.47 57.46 79.69
2018-06-30 467.60 60.60 76.33
2018-03-31 460.13 56.05 75.60
2017-12-31 452.44 38.60 82.18
2017-09-30 443.36 28.21 81.09
2017-06-30 435.77 20.59 81.36
2017-03-31 430.26 14.39 72.95
2016-12-31 423.47 24.63 72.61
2016-09-30 413.19 24.69 70.34
2016-06-30 397.81 19.90 67.87
2016-03-31 386.92 23.28 61.95
2015-12-31 368.95 22.33 57.96
2015-09-30 357.56 22.40 54.13
2015-06-30 345.22 27.64 49.18
2015-03-31 328.56 25.06 45.81
2014-12-31 314.71 19.96 43.06
2014-09-30 302.06 18.58 43.54
2014-06-30 292.91 16.03 44.66
2014-03-31 277.94 13.03 46.44
2013-12-31 272.59 12.66 46.20
2013-09-30 259.00 10.12 43.48
2013-06-30 245.42 7.57 40.75
2013-03-31 236.85 4.97 40.21
2012-12-31 228.29 2.36 39.67
2012-09-30 218.75 0.94 39.52
2012-06-30 209.22 -0.48 39.37

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Health Management International has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Health Management International used its assets more efficiently than the SG Healthcare industry average last year based on Return on Assets.
  • Health Management International's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Health Management International's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Health Management International has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Health Management International's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Health Management International's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Health Management International is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Health Management International's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Health Management International's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Health Management International Company Filings, last reported 1 month ago.

SGX:588 Past Debt and Equity Data
Date (Data in MYR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 264.71 326.83 59.62
2018-12-31 261.35 245.90 82.16
2018-09-30 257.53 241.43 92.08
2018-06-30 246.03 196.38 65.57
2018-03-31 236.90 95.92 70.69
2017-12-31 227.66 106.04 69.93
2017-09-30 190.31 144.64 78.31
2017-06-30 168.65 163.75 80.07
2017-03-31 148.24 210.80 120.89
2016-12-31 262.00 39.77 94.49
2016-09-30 249.42 40.77 88.09
2016-06-30 232.26 41.86 80.27
2016-03-31 231.44 36.89 66.18
2015-12-31 217.98 38.73 50.26
2015-09-30 205.42 42.47 40.07
2015-06-30 205.13 40.58 39.58
2015-03-31 185.39 39.65 35.47
2014-12-31 172.83 48.89 37.28
2014-09-30 152.19 55.61 26.20
2014-06-30 152.19 55.61 26.20
2014-03-31
2013-12-31 149.74 57.76 19.33
2013-09-30 149.74 57.76 19.33
2013-06-30 132.40 63.65 10.31
2013-03-31 132.40 63.65 10.31
2012-12-31 128.00 73.01 11.10
2012-09-30 128.00 73.01 11.10
2012-06-30 118.47 69.86 6.93
  • Health Management International's level of debt (123.5%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (37.5% vs 123.5% today).
  • Debt is well covered by operating cash flow (24.2%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 7x coverage).
X
Financial health checks
We assess Health Management International's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Health Management International has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Health Management International's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.21%
Current annual income from Health Management International dividends. Estimated to be 1.22% next year.
If you bought SGD2,000 of Health Management International shares you are expected to receive SGD24 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Health Management International's pays a lower dividend yield than the bottom 25% of dividend payers in Singapore (2.54%).
  • Health Management International's dividend is below the markets top 25% of dividend payers in Singapore (5.75%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SGX:588 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
Asia Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 26 Stocks 2%
Singapore Market Average Dividend Yield Market Cap Weighted Average of 276 Stocks 4%
Singapore Minimum Threshold Dividend Yield 10th Percentile 1.6%
Singapore Bottom 25% Dividend Yield 25th Percentile 2.5%
Singapore Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SGX:588 Future Dividends Estimate Data
Date (Data in MYR) Dividend per Share (annual) Avg. No. Analysts
2023-06-30
2022-06-30
2021-06-30 0.02 3.00
2020-06-30 0.02 4.00
2019-06-30 0.02 4.00
SGX:588 Past Annualized Dividends Data
Date (Data in MYR) Dividend per share (annual) Avg. Yield (%)
2019-02-11 0.020 1.210
2018-10-11 0.020 1.209
2018-05-09 0.020 1.124
2018-02-12 0.020 1.057
2017-11-03 0.010 0.497
2016-08-25 0.008 0.387
2009-10-12 0.000 0.000
2009-08-21 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Health Management International is not paying a notable dividend for Singapore, therefore no need to check if the payments are stable.
  • Health Management International is not paying a notable dividend for Singapore, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of Health Management International's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of Health Management International's dividends as it is not paying a notable one for Singapore.
Future Payout to shareholders
  • No need to calculate the sustainability of Health Management International's dividends in 3 years as they are not expected to pay a notable one for Singapore.
X
Income/ dividend checks
We assess Health Management International's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Health Management International afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Health Management International has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Health Management International's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Wei Chin
COMPENSATION MYR0
AGE 40
TENURE AS CEO 3.7 years
CEO Bio

Ms. Wei Jia Chin has been Managing Director of Mahkota Medical Centre & Regency Specialist Hospital at Regency Specialist Hospital Sdn Bhd since March 24, 2016. Ms. Chin served as the Group Chief Executive Officer of Health Management International Ltd since September 30, 2015. She served as the Chief Executive Officer of Regency Specialist Hospital Sdn Bhd since 2012. Ms. Chin was responsible for the strategic direction and operations of Regency Specialist Hospital. Ms. Chin served as Group General Manager of Health Management International Ltd. since 2010. She served as Senior Manager of Group Business Development Health Management International Limited from 2005 to 2010. She served as Program Development and Implementation Manager of Health Management International 2003 to 2004. She has been an Executive Director of Health Management International Ltd since October 28, 2014. M.s Chin holds a Bachelor of Arts (summa cum laude) in Economics and International Relations from Boston University, United States of America. She also has a Masters of Arts in International Relations from Johns Hopkins University, United States of America.

CEO Compensation
  • Insufficient data for Wei to compare compensation growth.
  • Wei's remuneration is lower than average for companies of similar size in Singapore.
Management Team Tenure

Average tenure and age of the Health Management International management team in years:

2.1
Average Tenure
51.5
Average Age
  • The tenure for the Health Management International management team is about average.
Management Team

See Khem Gan

TITLE
Executive Chairman & MD
AGE
72

Wei Chin

TITLE
Group CEO & Executive Director
AGE
40
TENURE
3.7 yrs

Lee Yow

TITLE
Chief Financial Officer
AGE
63
TENURE
0.2 yrs

Wei Yao Chin

TITLE
Chief Investment Officer & Executive Director
AGE
36
TENURE
0.2 yrs

Wei Shan Chin

TITLE
Group Marketing Manager

Serena Yong

TITLE
Chief People Officer
TENURE
1.7 yrs

May Tan

TITLE
Chief Financial Officer of Mahkota Medical Centre
TENURE
9.3 yrs

Choo Khim Jean Ong

TITLE
Chief Development Officer
TENURE
0.1 yrs

Noraini Binte Mohamed Abdul Latiff

TITLE
Company Secretary
TENURE
2.7 yrs

Horng Lim

TITLE
Financial Controller
TENURE
2.6 yrs
Board of Directors Tenure

Average tenure and age of the Health Management International board of directors in years:

4.6
Average Tenure
69
Average Age
  • The tenure for the Health Management International board of directors is about average.
Board of Directors

See Khem Gan

TITLE
Executive Chairman & MD
AGE
72
TENURE
20.3 yrs

Wei Chin

TITLE
Group CEO & Executive Director
AGE
40
TENURE
4.6 yrs

Wei Yao Chin

TITLE
Chief Investment Officer & Executive Director
AGE
36
TENURE
3.6 yrs

Chin Tan

TITLE
Independent Non Executive Director
AGE
69
TENURE
19.7 yrs

Annie Koh

TITLE
Lead Independent Director
TENURE
2.7 yrs

Way Cheah

TITLE
Independent Non Executive Director
AGE
69
TENURE
19.7 yrs

Peter Chong

TITLE
Independent Non-Executive Director
TENURE
1.4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (SGD) Value (SGD)
05. Dec 18 Buy Kabouter Management L.L.C. Company 03. Dec 18 03. Dec 18 502,700 SGD0.55 SGD278,116
01. Oct 18 Sell Kabouter Management L.L.C. Company 26. Sep 18 26. Sep 18 -432,700 SGD0.58 SGD-249,105
X
Management checks
We assess Health Management International's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Health Management International has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Do You Know What Health Management International Ltd's (SGX:588) P/E Ratio Means?

The formula for P/E is: Price to Earnings Ratio = Price per Share (in the reporting currency) ÷ Earnings per Share (EPS) Or for Health Management International: P/E of 25.91 = MYR1.64 (Note: this is the share price in the reporting currency, namely, MYR ) ÷ MYR0.063 (Based on the year to March 2019.) Is A High P/E Ratio Good? … Does Health Management International Have A Relatively High Or Low P/E For Its Industry? … The Verdict On Health Management International's P/E Ratio Health Management International has a P/E of 25.9.

Simply Wall St -

Is Health Management International Ltd (SGX:588) A Financially Sound Company?

Investors are always looking for growth in small-cap stocks like Health Management International Ltd (SGX:588), with a market cap of S$456m. … Assessing first and foremost the financial health is … since poor capital management may bring about bankruptcies,

Simply Wall St -

Is Health Management International Ltd (SGX:588) Trading At A 26% Discount?

How far off is Health Management International Ltd (SGX:588) from its intrinsic value? … Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. … Check out our latest analysis for Health Management International

Simply Wall St -

Do Institutions Own Health Management International Ltd (SGX:588) Shares?

If you want to know who really controls Health Management International Ltd (SGX:588), then you'll have to look at the makeup of its share registry. … So it's nice to see some insider ownership, because it may suggest that management is owner-oriented. … Health Management International is a smaller company with a market capitalization of S$461m, so it may still be flying under the radar of many institutional investors.

Simply Wall St -

Was Health Management International Ltd's (SGX:588) Earnings Growth Better Than The Industry's?

Understanding Health Management International Ltd's (SGX:588) performance as a company requires examining more than earnings from one point in time. … Today I will take you through a basic sense check to gain perspective on how Health Management International is doing by evaluating its latest earnings with its longer term trend as well as its industry peers' performance over the same period. … View our latest analysis for Health Management International?

Simply Wall St -

Why Health Management International Ltd (SGX:588) Could Be Worth Watching

Health Management International Ltd (SGX:588), which is in the healthcare business, and is based in Singapore,. … Let’s take a look at Health Management International’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change … Check out our latest analysis for Health Management International

Simply Wall St -

Why Health Management International Ltd (SGX:588) Looks Like A Quality Company

Health Management International has a ROE of 19%, based on the last twelve months. … That means that for every SGD1 worth of shareholders' equity, it generated SGD0.19 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

One Thing To Remember About The Health Management International Ltd (SGX:588) Share Price

Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … Any stock with a beta of greater than one is considered more volatile than the market, while those with a beta below one are either less volatile or poorly correlated with the market.

Simply Wall St -

Is Health Management International's 249% Share Price Increase Well Justified?

One great example is Health Management International Ltd (SGX:588) which saw its share price drive 249% higher over five years. … By comparing earnings per share (EPS) and and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. … Over half a decade, Health Management International managed to grow its earnings per share at 37% a year.

Simply Wall St -

Should You Like Health Management International Ltd’s (SGX:588) High Return On Capital Employed?

In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business. … Understanding Return On Capital Employed (ROCE). … ROCE measures the 'return' (pre-tax profit) a company generates from capital employed in its business.

Simply Wall St -

Company Info

Description

Health Management International Ltd, an investment holding company, provides private healthcare services in Singapore, Malaysia, and Indonesia. It owns and operates Mahkota Medical Centre, a 340-bed tertiary care hospital in Malacca, Malaysia; and Regency Specialist Hospital, a 218-bed tertiary care hospital in Johor, Malaysia. The company’s hospitals provide medical and surgical services, such as breast, cardiothoracic, hepatobiliary-pancreato-biliary, general, oral and maxillofacial, orthopedic and trauma, plastic and reconstructive, spine, ear, nose, and throat surgery services; and anesthesiology, cardiology, emergency physician, endocrinology, gastroenterology and hepatology, geriatrics, hematology and haemo-oncology, internal medicine, general dentistry, nephrology, neurology, neurosurgery, obstetrics and gynecology, gynae-oncology, oncology and radiotherapy, ophthalmology and vitreo retinal, orthodontics, pathology, pediatric, pediatric cardiology and neurology, psychiatric, radiology and interventional radiology, reproductive medicine, respiratory medicine, and urology services. Its medical and surgical services also include colorectal surgery, head and neck surgery, emergency medicine, gynecologic oncology, neonatology, and vascular and endovascular surgery, as well as plastic, cosmetic, and reconstruction surgery services. In addition, the company owns and operates HMI Institute of Health Sciences in Singapore that provides healthcare training and education services; and offers hospital management and consulting services. Further, it develops and leases a hospital building, as well as invests in properties. The company was founded in 1991 and is headquartered in Singapore.

Details
Name: Health Management International Ltd
588
Exchange: SGX
Founded: 1991
SGD452,162,490
837,337,946
Website: http://www.hmi.com.sg
Address: Health Management International Ltd
Suntec Tower One,
No. 12-10, 7 Temasek Boulevard,
Singapore,
038987,
Singapore
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SGX 588 Ordinary Shares Singapore Exchange SG SGD 15. Oct 1999
Number of employees
Current staff
Staff numbers
0
Health Management International employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/22 12:35
End of day share price update: 2019/05/22 00:00
Last estimates confirmation: 2019/05/15
Last earnings filing: 2019/05/13
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.